India’s Covaxin Has 77.8% Efficacy Rate Against Symptomatic COVID-19 Infection, Reveals Lancet Study

Nov 12, 2021 | EARNINGS

Covaxin recently joined the list of vaccines approved by the World Health Organisation (WHO) that includes COVID jabs produced by Pfizer/BioNTech, Moderna, AstraZeneca, Johnson & Johnson, Sinopharm, and Sinovac. Earlier this week, Bharat Biotech’s Chairman Krishna Ella stated that the approval came late due to criticism of the vaccine.

Read More

Pin It on Pinterest